Table 2.

Planned, delivered, and difference for the dose‐volume quantities of the targets and organs at risk.

		Patient	1	2	3	4	5
Prostate	D95	Plan	76.5	75.0	76.7	77.1	76.9
	(Gy)	Delivered	76.8	75.0	75.3	75.1	75.9
		% Diff	0.5	0.0	$-1.8$	$-2.6$	‐1.3
	D100	Plan	71.8	74.0	75.2	69.1	73.7
	(Gy)	Delivered	72.8	73.2	73.4	66.0	68.0
		% Diff	1.4	1.1	$-2.4$	$-4.5$	$-7.7$
	DVH Variation		0.6	0.6	1.0	1.2	0.9
PTV	D95	Plan	73.0	73.6	75.2	73.4	74.6
	(Gy)	Delivered	72.4	73.4	71.8	67.1	71.8
		% Diff	$-0.7$	$-0.3$	$-4.5$	$-8.6$	$-3.8$
	D100	Plan	60.8	57.6	68.7	63.0	65.9
	(Gy)	Delivered	59.6	64.2	62.9	50.4	58.2
		% Diff	$-2.0$	12.3	$-8.4$	$-20.2$	$-11.7$
	DVH Variation		0.7	0.6	1.7	2.4	1.6
Bladder	Mean	Plan	8.4	30.2	8.2	14.4	6.6
	(Gy)	Delivered	9.8	30.9	9.0	16.3	6.2
		%Diff	16.7	2.0	9.6	13.0	$-7.2$
	V70	Plan	1.7	7.1	2.4	3.9	1.4
	(%)	Delivered	2.6	6.2	2.4	1.1	0.6
	(%)	Abs. Diff	0.9	$-0.9$	0.0	$-2.8$	$-0.8$
	DVH Variation		1.5	1.5	1.1	3.5	0.9
Rectum	Mean	Plan	29.7	39.1	21.8	26.7	23.1
	(Gy)	Delivered	26.4	43.5	23.6	29.4	24.3
		%Diff	$-11.8$	11.1	8.5	9.8	5.5
	V70	Plan	4.7	5.1	0.0	1.3	1.4
	(%)	Delivered	3.0	7.7	0.0	3.8	1.1
	(%)	Abs. Diff	$-0.3$	2.6	0.0	2.5	$-1.3$
	DVH Variation		4.8	6.6	4.0	3.3	1.7